← Leaderboards
Rui Kong
Emory University
$4,825,382
Attributed
$4,825,382
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.1M · FY2021–25$2M$1.5M$1M$500K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,825,382 · 1
By mechanism
R01$4,825,382 · 1
Top collaborators
No co-investigators on record.
Most similar at Emory University
Same institution · by research overlap
- Mitsi A Blount$897,300
- Jeff M Sands$14,564,095
- Eric J Sorscher$13,371,665
- Mary R Galinski$18,988,233
- Francois J Villinger$61,853,654
Others in their field
Other Emerging Leaders on “Immunize”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$181,310,675
- Kevin Urdahl · Seattle Children'S Hospital$84,741,409
- Ted Ross · University Of Georgia$74,507,826
- Yunda Huang · Fred Hutchinson Cancer Center$73,602,469
- Tony Moody · Duke University$66,767,417
Research focus
ImmunizeImmunogenicImmunizationAntigensAntibodiesAmino AcidsAnimalsB-LymphocytesCarrier ProteinsCaviaCellsChikungunya VirusBindingCross ReactivityDesignAntibody ResponseEpitopesEvaluationFrequenciesFutureHeterogeneityHiv-1Hiv VaccineIn Vitro
Grant awards (6)
HIV-1 Fusion Peptide-directed Vaccine Design Using Virus-like Particles$879,691
R01 · FY2025 · AI · contact PI
HIV-1 Fusion Peptide-directed Vaccine Design Using Virus-like Particles$909,998
R01 · FY2024 · AI · contact PI
HIV-1 Fusion Peptide-directed Vaccine Design Using Virus-like Particles$150,000
R01 · FY2024 · AI · contact PI
HIV-1 Fusion Peptide-directed Vaccine Design Using Virus-like Particles$1,054,497
R01 · FY2023 · AI · contact PI
HIV-1 Fusion Peptide-directed Vaccine Design Using Virus-like Particles$907,275
R01 · FY2022 · AI · contact PI
HIV-1 Fusion Peptide-directed Vaccine Design Using Virus-like Particles$923,921
R01 · FY2021 · AI · contact PI